Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/autre/glycosylation-engineering-of-biopharmaceuticals/beck/descriptif_2913491
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=2913491

Glycosylation Engineering of Biopharmaceuticals, 2013 Methods and Protocols Methods in Molecular Biology Series, Vol. 988

Langue : Anglais

Coordonnateur : Beck Alain

Couverture de l’ouvrage Glycosylation Engineering of Biopharmaceuticals

Glyco-engineering is being developed as a method to control the composition of carbohydrates and to enhance the pharmacological properties of monoclonal antibodies (mAbs) and other proteins.  In Glycosylation Engineering of Biopharmaceuticals: Methods and Protocols, experts in the field provide readers with production and characterization protocols of glycoproteins and glyco-engineered biopharmaceuticals with a focus on mAbs. The volume is divided in four complementary parts dealing with glyco-engineering of therapeutic proteins, glycoanalytics, glycoprotein complexes characterization, and PK/PD assays for therapeutic antibodies.  Written in the highly successful Methods in Molecular Biology? series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.

 

Authoritative and cutting-edge, Glycosylation Engineering of Biopharmaceuticals: Methods and Protocols serves as an ideal guide for scientists striving to push forward the exciting field of engineered biopharmaceuticals.

Part I: Glyco-Engineering of Therapeutic Proteins

 

1. Engineering of Therapeutic and Diagnostic O-Glycans on Recombinant Mucin-Type Immunoglobulin Fusion Proteins Expressed in CHO Cells

            Linda Lindberg, Jining Liu, and Jan Holgersson

 

2. Engineering a Human-Like Glycosylation to Produce Therapeutic Glycoproteins Based on 6-Linked Sialylation in CHO Cells

            Nassimal El Maï, Sandrine Donadio-Andréi, Chloé Iss, Valérie Calabro, and Catherine Ronin

 

3. Glycoengineered Pichia-Based Expression of Monoclonal Antibodies

            Dongxing Zha

 

4. N-Glycosylation Humanization for Production of Therapeutic Recombinant Glycoproteins in Saccharomyces cerevisiae

            Christelle Arico, Christine Bonnet, and Christophe Javaud

 

5. Engineering the Baculovirus Genome to Produce Galactosylated Antibodies in Lepidopteran Cells

            Sylvie Juliant, Marylêne Lévêque, Pierre Cérutti, Annick Ozil, Sylvie Choblet, Marie-Luce Violet, Marie-Christine Slomianny, Anne Harduin-Lepers, and Martine Cérutti

 

Part II: Glycoanalytics

 

6. Nano LC Chips MS/MS for the Characterization of N-Glycopeptides Generated from Trypsin Digestion of a Monoclonal Antibody

            Elsa Wagner-Rousset, Christine Schaeffer-Reiss, Audrey Bednarczyk, Nathalie Corvaïa, Alain Van Dorsselaer, and Alain Beck

 

7. Cetuximab Fab and Fc N-Glycan Fast Characterization Using IdeS Digestion and Liquid Chromatography Coupled to Electrospray Ionization Mass Spectrometry

            Marie-Claire Janin-Bussat, Laure Tonini, Céline Huillet, Olivier Colas, Christine Klinguer-Hamour, Nathalie Corvaïa, and Alain Beck

 

8. Therapeutic Antibody Glycosylation Analysis: A Contract Research Organization Perspective in the Frame of Batch Release or Comparability Support

            Arnaud Delobel, Fabrice Cantais, Anicet Catrain, Erell Dereux, and Géry Van Vyncht

 

9. Mass Spectrometric Analysis of O-Linked Oligosaccharides from Various Recombinant Expression Systems

            Diarmuid T. Kenny, Stefan Gaunit, Catherine A. Hayes, Anki Gustafsson, Magnus Sjöblom, Jan Holgersson, and Niclas G. Karlsson

 

10. Assessing Fc Glycan Heterogeneity of Therapeutic Recombinant Monoclonal Antibodies Using NP-HPLC

            T. Shantha Raju

 

11. Application of Capillary Electrophoresis in Glycoprotein Analysis

            Richard R. Rustandi, Carrie Anderson, and Melissa Hamm

 

12. Characterization of Glycoprotein Biopharmaceutical Products by Caliper LC90 CE-SDS Gel Technology

            Grace Chen, Sha Ha, and Richard R. Rustandi

 

13. Hydrophobic Interaction Chromatography to Analyze Glycoproteins

            Richard R. Rustandi

 

14. Lectin Glycoprofiling of Recombinant Therapeutic Interleukin-7

            Ludovic Landemarre and Eric Duverger

 

15. Analysis of Monoclonal Antibodies by Sedimentation Velocity Analytical Ultracentrifugation

            W. Blaine Stine, Jr.

 

Part III: Glycoprotein Complexes Characterization

 

16. Noncovalent Mass Spectrometry for the Characterization of Antibody/Antigen Complexes

            Cédric Atmanene, Elsa Wagner-Rousset, Nathalie Corvaïa, Alain Van Dorsselaer, Alain Beck, and Sarah Sanglier-Cianferani

 

17. Conformational Analysis of Recombinant Monoclonal Antibodies with Hydrogen/Deuterium Exchange Mass Spectrometry

            Damian Houde and John R. Engen

 

18. Epitope Mapping of Antibodies by Mass Spectroscopy: A Case Study

            Victor H. Obungu, Valentina Gelfanova, and Lihua Huang

 

Part IV: PK/PD Assays for Therapeutic Antibodies

 

19. Evaluation of Antibody-Dependent Cell Cytotoxicity Using Lactate Deshydrogenase (LDH) Measurement

            Matthieu Broussas, Lucile Broyer, and Liliane Goetsch

 

20. Evaluation of Complement Dependent Cytotoxicity Using ATP Measurement and C1q / C4b Binding

            Lucile Broyer, Liliane Goetsch, and Mattthieu Broussas

 

21. Capture of the Human IgG1 Antibodies by Protein A for the Kinetic Study of h-IgG / FcgR Interaction Using SPR-Based Biosensor Technology

            Thierry Champion and Alain Beck

 

22. Mass Spectrometry Protocol for the Absolute Quantification of a Monoclonal Antibody in Serum with Immunopurification

            François Becher, Mathieu Dubois, François Fenaille, and Eric Ezan

Presents detailed protocols on the production and characterization of glycoproteins and glyco-engineered biopharmaceuticals

Contains a special focus on monoclonal antibodies (mAbs)

Features expert tips and key implementation advice to guarantee successful results

Date de parution :

Ouvrage de 355 p.

17.8x25.4 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

152,96 €

Ajouter au panier

Date de parution :

Ouvrage de 355 p.

17.8x25.4 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

179,34 €

Ajouter au panier
En continuant à naviguer, vous autorisez Lavoisier à déposer des cookies à des fins de mesure d'audience. Pour en savoir plus et paramétrer les cookies, rendez-vous sur la page Confidentialité & Sécurité.
FERMER